Total Chemical Synthesis of a Nonfibrillating Human Glycoinsulin
Chemical Stability
DOI:
10.1021/jacs.9b11424
Publication Date:
2019-12-18T16:35:43Z
AUTHORS (8)
ABSTRACT
Glycosylation is an accepted strategy to improve the therapeutic value of peptide and protein drugs. Insulin its analogues are life-saving drugs for all type I 30% II diabetic patients. However, they can readily form fibrils which a significant problem especially their use in insulin pumps. Because solubilizing hydration effects sugars, it was thought that glycosylation could inhibit fibril formation lead more stable formulation. Since enzymatic results heterogeneous products, we developed novel chemical produce homogeneous glycoinsulin (disialo-glycoinsulin) excellent yield (∼60%). It showed near-native binding affinity receptors A B vitro high glucose-lowering vivo, irrespective route administration (s.c. vs i.p.). The retained insulin-like helical structure exhibited improved stability human serum. Importantly, our disialo-glycoinsulin analogue does not at both concentration temperature. Therefore, candidate clinical
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (26)
CITATIONS (53)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....